The first evidence implicating BDNF in AD and PD dates back to the 1990’s, and for both pathologies, reduced levels of mRNA or proteins were described either in postmortem brains of humans or mice models [109,110,111,112]. The gene discussed is BDNF; the disease is Parkinson disease.